When producing a quality vaccine, all manufacturers must confirm the purity as well as the stability of their formulation and final product. Sample quantity and measurement time are often the throughput bottlenecks encountered during the process. As PerkinElmer’s LabChip GXII Touch protein characterization system addresses these specific gaps, we’ve developed a literature-centric webinar. In this webinar you will learn: The vaccine development and manufacturing process The key applications of mi...
원문링크 : Accelerating Vaccine Development Using a Next Generation Microfluidic CE Platform
네이버 블로그
티스토리
커뮤니티